ESG Tracker
  • Companies
  • Rankings
  • Portfolios
  • My Portfolios
  • Log In Log Out
  • Contact

← Back to search

Tango Therapeutics Inc

TNGX · NASDAQ

Research and Development in Biotechnology

Tango Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops drugs and medicines for the treatment of patients. Tango Therapeutics serves customers in the State of Massachusetts.

Market Data

Price $16.50 +0.05 (+0.30%)
Market Cap$2.35B
P/E Ratio—
EPS$—
52W High$17.63
52W Low$1.03
Beta1.74

Data from Finnhub · Updated Mar 11, 2026

Products and Services
  • Company Search
  • Rankings
  • Portfolios
About ESG Tracker
  • FAQ
Legal & Security
  • Disclosures
  • Privacy Policy
Contact
  • Contact Us
ESG Tracker

ESG Tracker is for informational purposes only and does not constitute investment advice. The operator of this site is not a registered investment advisor. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.

Public ESG data sourced from Public Company ESG Ratings Dataset by esgcompare.org, licensed under CC BY-NC-SA 4.0. This site is non-commercial and for informational purposes only.